• Hero Banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Buying or Selling a Practice
Hospital Design
Leadership & Personal Growth
Personnel Management
Practice Finances
Practice Operations
Technology
Wellbeing & Lifestyle
Continuing Education
Conferences
Live Conferences
Conference News
Conference Proceedings
Resources
CBD in Pets
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Movora appoints new co-CEO

December 1, 2022
dvm360 Staff

The company has tapped its current COO Colleen Flesher to lead alongside Guy Spörri

Movora announced Collen Flesher, its current COO, has been appointed as its new co-CEO of veterinary MedTech leader Movora, an operating company of Vimian. Beginning her duties as co-CEO today, Flesher will succeed Patrick Gendreau and Christopher Sidebotham after both decided to step down.

"I would like to sincerely thank Patrick and Chris who over the past thirty years have founded and grown two successful, leading orthopedics businesses in the US with remarkable commercial and innovation capabilities. I am thankful for their exceptional leadership throughout the integration into Vimian and the formation of Movora, today a global leader in veterinary orthopedics," says Fredrik Ullman, PhD, MScEng, MEng, BSc, CEO of Vimian Group, in an organizational release.1

According to the release, Flesher has over 20 years of experience in leadership positions in the global MedTech sector. She worked for almost 10 years with Johnson & Johnson's MedTech divisions serving in various managerial positions within the development, innovation, marketing, product, and sales. After she left Johnson & Johnson, she served as president & general manager for Lima Corporate in the US before making her way to Movora. Flesher will lead alongside co-CEO Guy Spörri.

Advertisement

“Flesher is a highly appreciated leader with significant experience from the MedTech sector. With Colleen onboard, we are now ready to take the next step in our succession plans for Movora. Together with Co-CEO Guy Spörri and the rest of the leadership team in Movora, we will continue to deliver on our strategic agenda strengthening and broadening our global position in veterinary MedTech," concluded Ullman.1

Reference

Colleen Flesher Appointed Co-CEO for Movora. News release. Movora. December 1, 2022. Accessed December 1, 2022. https://prnmedia.prnewswire.com/news-releases/colleen-flesher-appointed-co-ceo-for-movora-301690215.html

Related Content:

Business
CityVet names new chief strategy officer
CityVet names new chief strategy officer
Hannah Pet Hospital names new CEO
Hannah Pet Hospital names new CEO
CityVet Celina opens in Prosper, Texas
CityVet Celina opens in Prosper, Texas

Advertisement

Latest News

This week on dvm360.com: dvm360® continues to celebrate Pride Month, and other veterinary news

3 must-sees on creating an inclusive work culture

CityVet names new chief strategy officer

Workplace bottlenecks in the LGBTQIA+ community

View More Latest News
Advertisement